Legal & Tax Updates [Back to list]
BIR Seeks to Expedite the Issuance of Authority to Release Imported Goods for VAT-Exempt Drugs and Medicines
The Bureau of Internal Revenue (“BIR”) issued Revenue Memorandum Order No. 20-2022(“RMO 20-2022”) which effectively modifies RMO No.35-2002, the issuance which sets the guidelines for the issuance Authority to Release Imported Goods (“ATRIG”). The BIR seeks to eliminate undue delays in the processing of ATRIG specific to importation of VAT-exempt drugs and medicines prescribed for diabetes, high cholesterol, hypertension, cancer, mental illness, tuberculosis, and kidney diseases covered under Section 109(AA) of the Tax Code.
The amendments contained in the said RMO include:
Policies and Guidelines Under RMO No.35-2002 | Modifications |
Section II (5): | The ATRIG shall be processed, approved, and issued within one (l) day from the time of the actual receipt of the application, in cases where the application for ATRIG is supported by 6omplete documents and there is no legal/factual issue on the taxability of the imported article. The BIR will only stamp the application ss "received" when documentation is complete with and there is no discrepancy noted. |
Section IV (2):
| The approval of ATRIGs processed by the above processing offices shall be made by the following:
|
Section III (A):
| 1. Prepare the transmittal letter addressed to BOC covering all approved ATRIGs for the day, for signature by the approving official.
|
All revenue issuances or portions inconsistent herewith are amended, modified, or revoked accordingly.
The full text of RMO 20-2022 can be found here.